As well as HR and HER2 status, some studies have indicated that the histological subtype of the breast cancer also plays an important role in predicting the response to adjuvant chemotherapy and/or neoadjuvant chemotherapy (NAC) [16–19]. Here, HR is linked to breast carcinoma.